Cargando…
Signaling cascades in the failing heart and emerging therapeutic strategies
Chronic heart failure is the end stage of cardiac diseases. With a high prevalence and a high mortality rate worldwide, chronic heart failure is one of the heaviest health-related burdens. In addition to the standard neurohormonal blockade therapy, several medications have been developed for chronic...
Autores principales: | He, Xin, Du, Tailai, Long, Tianxin, Liao, Xinxue, Dong, Yugang, Huang, Zhan-Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035186/ https://www.ncbi.nlm.nih.gov/pubmed/35461308 http://dx.doi.org/10.1038/s41392-022-00972-6 |
Ejemplares similares
-
Circle the Cardiac Remodeling With circRNAs
por: Yang, Tiqun, et al.
Publicado: (2021) -
Loss of m(6)A Methyltransferase METTL5 Promotes Cardiac Hypertrophy Through Epitranscriptomic Control of SUZ12 Expression
por: Han, Yanchuang, et al.
Publicado: (2022) -
Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure
por: Yan, Youchen, et al.
Publicado: (2022) -
The Failing Heart
por: Wells, S. Russell
Publicado: (1907) -
Emerging nanomedicine-based therapeutics for hematogenous metastatic cascade inhibition: Interfering with the crosstalk between “seed and soil”
por: Wu, Junyu, et al.
Publicado: (2021)